Genomics Insights Day Costa Rica

Date: July 28, 2026 - July 28, 2026
Type: In-person
Location: LATAM
Areas of Interest: Blood Cancers, Exomes

El GENOMiCS INSIGHTS Day Costa Rica se llevará a cabo el próximo 28 de julio, en el Hotel Four Points. El evento contará con la participación de especialistas y clientes que compartirán su experiencia real en la práctica clínica, abordando temas de alto impacto: desde el estudio de exoma completo en población costarricense hasta la caracterización molecular de neoplasias mieloides mediante secuenciación NGS.

La jornada reunirá experiencias concretas de clientes que utilizan la plataforma SOPHiA DDM™ en su día a día, ofreciendo una perspectiva directa sobre su impacto en el diagnóstico molecular y la toma de decisiones clínicas. El evento culminará con una mirada hacia el horizonte de la genómica en hemato-oncología, presentada por nuestro equipo de expertos.

A continuación, encontrará la agenda preliminar del evento

What: SOPHiA GENETICS Exclusive Networking event

Where: Four Points by Sheraton Sabana

Date: 28 de julio

Time: 14h00-17h:00

Agenda

14:00 – 14:30
Experiencia del estudio de exoma completo en población costarricense
Dr. Carlos Santamaría, PhD
Jefe de División de Diagnóstico Molecular, Hospital Nacional de Niños, San José, Costa Rica

14:30 – 15:00
Caracterización molecular de una cohorte colombiana de neoplasias mieloides, mediante secuenciación NGS con SOPHiA DDM™
Paula Andrea Rueda Gaitán, MSc
Coordinadora de Bioinformática, Clínica Colsanitas, Colombia

15:00 - 15:30
What’s Next in Hemato-Oncology Genomics
Brandon Bullough, Global Product Director, Hematologic Oncology
SOPHiA GENETICS

15:30 – 17:00
Cocktails and Networking

Why Attend?

Descubra SOPHiA DDM™: una plataforma compatible con múltiples tecnologías, con infinitas posibilidades

Conozca cómo SOPHiA DDM™ permite realizar análisis precisos en diversas áreas de la medicina, desde oncología hasta enfermedades raras.

Aborde los desafíos actuales de la práctica clínica y la investigación

Participe en una conversación sobre el futuro de las instituciones de salud e investigación y descubra cómo aprovechar el potencial de los datos de secuenciación de nueva generación (NGS) para generar resultados rápidos, sólidos y accionables que faciliten una toma de decisiones informada.

Conecte con líderes de opinión y expertos del sector

Interactúe con colegas, investigadores y usuarios de la plataforma SOPHiA DDM™ en un espacio diseñado para el intercambio de conocimientos, experiencias y oportunidades de colaboración científica.

Register Now

URL

This field is for validation purposes and should be left unchanged.

First Name(Required)

Last Name(Required)

Institution(Required)

Job Title(Required)

Area of Interest(Required)

Email(Required)

Phone

Country(Required)

Select US State(Required)

Privacy Policy(Required)

By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy

Marketing Opt-In

I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time.

3rd Party Opt-In

I agree that SOPHiA GENETICS may share my webinar registration details with 3rd parties, and that I may receive marketing communications from these 3rd parties. I understand that I can withdraw my consent at any time.

This field is hidden when viewing the form

Job Title/Industry(Required)

CAPTCHA

Disclaimer notice:
The term SOPHIA used by the speaker refers to SOPHiA GENETICS and its products.
The opinions expressed during this presentation are those of the speakers and may not represent the opinions of SOPHiA GENETICS.
SOPHiA GENETICS does not provide support in the validation of custom products for clinical use.
SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us at [email protected] to obtain the appropriate product information for your country of residence.

SOPHiA GENETICS products are for Research Use Only and not for use in diagnostic procedures unless specified otherwise.

SOPHiA DDM™ Dx Hereditary Cancer Solution, SOPHiA DDM™ Dx RNAtarget Oncology Solution and SOPHiA DDM™ Dx Homologous Recombination Deficiency Solution are available as CE-IVD products for In Vitro Diagnostic Use in the European Economic Area (EEA), the United Kingdom and Switzerland. SOPHiA DDM™ Dx Myeloid Solution and SOPHiA DDM™ Dx Solid Tumor Solution are available as CE-IVD products for In Vitro Diagnostic Use in the EEA, the United Kingdom, Switzerland, and Israel. Information about products that may or may not be available in different countries and if applicable, may or may not have received approval or market clearance by a governmental regulatory body for different indications for use. Please contact us to obtain the appropriate product information for your country of residence.

All third-party trademarks listed by SOPHiA GENETICS remain the property of their respective owners. Unless specifically identified as such, SOPHiA GENETICS’ use of third-party trademarks does not indicate any relationship, sponsorship, or endorsement between SOPHiA GENETICS and the owners of these trademarks. Any references by SOPHiA GENETICS to third-party trademarks is to identify the corresponding third-party goods and/or services and shall be considered nominative fair use under the trademark law.

SOPHiA DDM™ Overview

SOPHiA DDM™ for Genomics

SOPHiA DDM™ for Radiomics

SOPHiA DDM™ for Multimodal

Professional Services